Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol vs Aspirin for Cardiovascular Event Prevention in High-Risk Type 2 Diabetes
NCT07719894Phase 4Recruiting
- Sponsor
- Seoul National University Bundang Hospital
- Start
- May 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in type 2 diabetes mellitus (T2DM), atherosclerosis, sponsored by Seoul National University Bundang Hospital. Started May 2026; status: recruiting.
02
Drugs
cilostazol
03
Conditions
type 2 diabetes mellitus (T2DM)atherosclerosis
Beyond the preview
Go deeper on NCT07719894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07719894.